Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharmacol Toxicol ; 77(6): 391-6, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8835365

RESUMO

The present study analyses the effects of simvastatin, a specific inhibitor of the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA reductase) in male Syrian hamsters fed a standard diet or a diet supplemented with 0.12% cholesterol and 20% coconut oil. In hamsters fed the standard diet, gastric administration of simvastatin (10 mg/kg/day) during 12 days was found to be lethal and to have hepatotoxic and nephrotoxic effects. This toxicity was exacerbated in hamsters fed a hyperlipidaemic diet and was preceded by a progressive anorexia and loss of body weight. Marked elevations in serum aspartate and alanine aminotransferase activities were associated with the organ lesions. All elevated biochemical changes and morphological alterations were prevented or reversed by coadministration of mevalonate, the product of the HMG-CoA reductase. It is suggested that the dramatic effect of simvastatin could result from depletion of a non-sterol metabolite of mevalonate in spite of a lack of protective effects of farnesol and geranylgeraniol in the following study. The toxicity of simvastatin could indeed result from the low basal activity of HMG-CoA reductase in hamster liver coupled with a prolonged inhibition of mevalonate synthesis.


Assuntos
Inibidores de Hidroximetilglutaril-CoA Redutases , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Lovastatina/análogos & derivados , Ácido Mevalônico/farmacologia , Administração Oral , Alanina Transaminase/metabolismo , Animais , Aspartato Aminotransferases/metabolismo , Peso Corporal/efeitos dos fármacos , Cricetinae , Gorduras na Dieta/administração & dosagem , Ingestão de Alimentos/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Fígado/metabolismo , Fígado/patologia , Lovastatina/administração & dosagem , Lovastatina/antagonistas & inibidores , Lovastatina/toxicidade , Masculino , Necrose , Sinvastatina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...